SMSPHARMAPharmaceuticals
Sms Pharmaceuticals Ltd — Cash Flow Statement
₹374.85
-5.18%
Sms Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -41.67 Cr | -2.04 Cr | -7.47 Cr | 17.81 Cr | — |
| Repayment Of Debt | -44.10 Cr | -37.76 Cr | -43.06 Cr | -36.67 Cr | — |
| Issuance Of Debt | 74.53 Cr | 65.29 Cr | 35.29 Cr | 46.08 Cr | — |
| Issuance Of Capital Stock | 38.09 Cr | 28.48 Cr | 0.00 | — | — |
| Capital Expenditure | -123.38 Cr | -52.16 Cr | -29.92 Cr | -27.25 Cr | — |
| End Cash Position | 41.40 Cr | 36.04 Cr | 7.38 Cr | 46.58 Cr | — |
| Beginning Cash Position | 36.04 Cr | 7.31 Cr | 46.58 Cr | 40.42 Cr | — |
| Changes In Cash | 5.36 Cr | 28.73 Cr | -39.27 Cr | 6.16 Cr | — |
| Financing Cash Flow | 47.08 Cr | 30.68 Cr | -31.97 Cr | -11.75 Cr | — |
| Interest Paid Cff | -17.35 Cr | -21.75 Cr | -20.93 Cr | -17.71 Cr | — |
| Cash Dividends Paid | -3.39 Cr | -2.54 Cr | -2.54 Cr | -2.54 Cr | — |
| Net Common Stock Issuance | 38.09 Cr | 28.48 Cr | 0.00 | — | — |
| Common Stock Issuance | 38.09 Cr | 28.48 Cr | 0.00 | — | — |
| Net Issuance Payments Of Debt | 30.43 Cr | 27.53 Cr | -7.77 Cr | 9.41 Cr | — |
| Net Short Term Debt Issuance | 10.80 Cr | 20.21 Cr | 25.88 Cr | -2.95 Cr | — |
| Short Term Debt Issuance | 10.80 Cr | 20.21 Cr | 25.88 Cr | 0.89 Cr | — |
| Net Long Term Debt Issuance | 19.63 Cr | 7.32 Cr | -33.64 Cr | 12.35 Cr | — |
| Long Term Debt Payments | -44.10 Cr | -37.76 Cr | -43.06 Cr | -32.84 Cr | — |
| Long Term Debt Issuance | 63.72 Cr | 45.09 Cr | 9.41 Cr | 45.19 Cr | — |
| Investing Cash Flow | -123.43 Cr | -52.07 Cr | -29.76 Cr | -27.15 Cr | — |
| Net Other Investing Changes | -0.27 Cr | -0.16 Cr | -0.09 Cr | -0.20 Cr | — |
| Interest Received Cfi | 0.17 Cr | 0.16 Cr | 0.16 Cr | 0.28 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | -0.17 Cr | 0.00 | — |
| Purchase Of Investment | 0.00 | 0.00 | -0.17 Cr | 0.00 | — |
| Net PPE Purchase And Sale | -123.32 Cr | -52.07 Cr | -29.66 Cr | -27.23 Cr | — |
| Sale Of PPE | 0.06 Cr | 0.09 Cr | 0.26 Cr | 0.02 Cr | — |
| Purchase Of PPE | -123.38 Cr | -52.16 Cr | -29.92 Cr | -27.25 Cr | — |
| Operating Cash Flow | 81.71 Cr | 50.12 Cr | 22.45 Cr | 45.06 Cr | — |
| Taxes Refund Paid | -19.83 Cr | -15.40 Cr | -4.60 Cr | -14.92 Cr | — |
| Change In Working Capital | -43.08 Cr | -54.55 Cr | -31.29 Cr | -58.38 Cr | — |
| Change In Other Current Liabilities | 6.18 Cr | 4.17 Cr | -4.31 Cr | -4.00 Cr | — |
| Change In Other Current Assets | 4.64 Cr | -8.85 Cr | -0.48 Cr | -4.19 Cr | — |
| Change In Payable | -37.41 Cr | 43.87 Cr | 42.44 Cr | 7.42 Cr | — |
| Change In Prepaid Assets | 1.53 Cr | 4.31 Cr | 3.29 Cr | -1.46 Cr | — |
| Change In Inventory | -51.03 Cr | -10.20 Cr | 27.60 Cr | -113.31 Cr | — |
| Change In Receivables | 33.00 Cr | -87.85 Cr | -99.83 Cr | 57.16 Cr | — |
| Other Non Cash Items | 17.37 Cr | 22.47 Cr | 20.95 Cr | 17.59 Cr | — |
| Depreciation And Amortization | 34.34 Cr | 31.52 Cr | 32.13 Cr | 32.15 Cr | — |
| Depreciation | 34.34 Cr | 31.52 Cr | 31.42 Cr | 31.44 Cr | — |
| Pension And Employee Benefit Expense | -0.38 Cr | -0.20 Cr | -0.34 Cr | -0.04 Cr | — |
| Gain Loss On Investment Securities | -0.02 Cr | -0.04 Cr | 0.05 Cr | -20000.00 | — |
| Net Income From Continuing Operations | 92.34 Cr | 66.11 Cr | 5.35 Cr | 68.50 Cr | — |
| Amortization Cash Flow | — | 0.91 Cr | 0.71 Cr | 0.71 Cr | 0.43 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | 0.07 Cr | -1000.00 | — |
| Short Term Debt Payments | — | — | 0.00 | -3.84 Cr | -2.02 Cr |
| Net Other Financing Charges | — | — | — | -1000.00 | 1000.00 |
| Provisionand Write Offof Assets | — | — | — | 0.00 | 0.08 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sms Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.